Case report: metolazone-associated hypercalcemia and acute pancreatitis.
Metolazone-induced acute pancreatitis and hypercalcemia are described in a 58-year-old woman with severe congestive cardiac failure. Her symptoms and laboratory abnormalities rapidly resolved upon discontinuation of metolazone. Both clinical and laboratory findings make other etiologies for the patient's pancreatitis extremely unlikely. The pathophysiology of thiazide-related hypercalcemia and pancreatitis is reviewed. To our knowledge, neither hypercalcemia nor the combination of acute pancreatitis with hypercalcemia has been reported previously in association with metolazone therapy, and the association of pancreatitis and metolazone has been noted previously only once.
Anderson
P E
PE
Department of Internal Medicine, St. Elizabeth Hospital Medical Center, Youngstown, OH 44501-1790.
Ellis
G G
GG
Austin
S M
SM
D000208:Acute Disease; D005260:Female; D006333:Heart Failure / Q000188:drug therapy; D006801:Humans; D006934:Hypercalcemia / Q000139:chemically induced*; D006973:Hypertension / Q000188:drug therapy; D008788:Metolazone / Q000009:adverse effects*; D008875:Middle Aged; D010195:Pancreatitis / Q000139:chemically induced*
D008788:Metolazone